Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (ATLAS)

This study has been terminated.
(Results from a pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.)
Information provided by (Responsible Party):
Biogen Identifier:
First received: November 23, 2011
Last updated: July 28, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)